Overview

Effect of High-dose Naloxone Following Third Molar Extraction

Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Recent studies have focused on the role of endogenous opioids on central sensitization. Central sensitization is known to be impaired or altered in chronic pain conditions, as fibromyalgia or chronic tension headache. Animal studies have shown reinstatement of mechanical hypersensitivity following naloxone administration after resolution of an injury. This suggests latent sensitization. In the present study, the investigators hypothesize that a high-dose target-controlled naloxone infusion (total dose: 3.25 mg/kg) can reinstate pain and hyperalgesia 6-8 weeks after a unilateral primary open groin hernia repair procedure. The investigators aim to show that latent sensitization is present in humans and is modulated by endogenous opioids.
Phase:
Phase 2
Details
Lead Sponsor:
mads u werner
Collaborator:
University of Kentucky
Treatments:
Naloxone